IOL Chemicals

IOLCP03 May 2024

Pharmaceuticals

₹

+2.50 (+0.64%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in IOL Chemicals

IOL Chemicals

Pharmaceuticals

IOLCP03 May 2024

₹

+2.50 (+0.64%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
06-Feb-2024	D	The Board of Directors in its meeting held on 6th February 2024 declared an Interim dividend of Rs 5/- (50%) per equity share of face value of Rs 10/-each for the Financial year 2023-24	16-Feb-2024
07-Feb-2023	D	Pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our letter dated 1st February 2023, we wish to inform you that the Board of Directors in its meeting held on today i.e. 7th February 2023 has inter alia considered and approved: Declared an Interim Dividend of Rs. 4/- (Rupees four only) per Equity Share of Face Value Rs.10/- each for the Financial Year 2022-23.	17-Feb-2023
04-Feb-2022	D	Pursuant to Regulations 30 & 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors in its meeting held on today i.e. 4th February 2022 has inter alia considered and approved the following: Declared an Interim Dividend of Rs. 4/- (Rupees Four Only) per Equity Share of Face Value Rs.10/- each for the Financial Year 2021-222. Fixed 16th February 2022 (Wednesday) as the Record Date to determine the names of the equity shareholders, who shall be entitled to receive the above said Interim Dividend. The payment of the Interim Dividend shall be made to the eligible shareholders before 5th March 2022.	15-Feb-2022
04-Jun-2021	D	Pursuant to Regulations 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors in its meeting held on today i.e. 4th June 2021 has recommended Final Dividend of Rs 2/- per shares (i.e. 20 % on the face value of Rs 10/- each share) for the financial year 2020-21, the same will be paid upon declaration by the shareholders in the 34th Annual General Meeting of the Company. Record date for payment of dividend shall be communicated in due course.	08-Sep-2021
06-Nov-2020	D	IOL Chemicals & Pharmaceuticals Ltd has informed BSE that the Board of Directors at its meeting held on November 06, 2020, inter alia, has declared the Interim Dividend of Rs. 4/- (Rupees four only) per share i.e. @ 40% per fully paid up equity share of Rs 10/- each for the financial year 2020-21.	17-Nov-2020
11-Mar-2020	D	Pursuant to Regulations 30 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors in its meeting held on today i.e. 11th March, 2020 have declared 1st Interim Dividend of Rs 3.00 (Rupees three only) i.e. @ 30% per fully paid up equity share of Rs 10.00 each for the financial year 2019-20. As already communicated, the Record Date for determining the eligibility of Shareholders for payment of Interim Dividend is Thursday, the 19th March 2020. The said interim dividend will be credited/ dispatched to the shareholders by 10th April 2020 i.e. within 30 days from the date of declaration. The meeting of Board of Directors commenced at 03:00 PM and concluded at 04:15 PM. This is for your information & record. Update with regard to Payment of Interim Dividend 2019-20 (As Per BSE Announcement Dated on 10.04.2020)	18-Mar-2020
06-Feb-2024	BC	The Board of Directors in its meeting held on 6th February 2024 declared an Interim dividend of Rs 5/- (50%) per equity share of face value of Rs 10/-each for the Financial year 2023-24	31-Mar-2024
06-Feb-2024	BC	Rs.5.0000 per share(50%)Interim Dividend	16-Feb-2024
06-Feb-2024	BC	50% Interim Dividend	16-Feb-2024
29-Jan-2024	BC	IOL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2024 inter alia to consider and approve Audited Financial Results	06-Feb-2024
30-Oct-2023	BC	IOL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve the Audited Financial Resu	08-Nov-2023

Announcement Date06-Feb-2024

Ex Dividend Date16-Feb-2024

Dividend(%)50

Announcement Date07-Feb-2023

Ex Dividend Date17-Feb-2023

Dividend(%)40

Announcement Date04-Feb-2022

Ex Dividend Date15-Feb-2022

Dividend(%)40

Announcement Date04-Jun-2021

Ex Dividend Date08-Sep-2021

Dividend(%)20

Announcement Date06-Nov-2020

Ex Dividend Date17-Nov-2020

Dividend(%)40

Announcement Date11-Mar-2020

Ex Dividend Date18-Mar-2020

Dividend(%)30

No Rights has been declared by IOLCP

Book Closure

Record Date	Split Date	Purpose
31-Mar-2024	-	The Board of Directors in its meeting held on 6th February 2024 declared an Interim dividend of Rs 5/- (50%) per equity share of face value of Rs 10/-each for the Financial year 2023-24
16-Feb-2024	-	Rs.5.0000 per share(50%)Interim Dividend
16-Feb-2024	-	50% Interim Dividend
06-Feb-2024	-	IOL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2024 inter alia to consider and approve Audited Financial Results
08-Nov-2023	-	IOL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve the Audited Financial Resu

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
IOL Chemicals & Pharmaceuticals Ltd ₹394.90(+2.50/0.64%)	394.90	+2.50	2,318.28	-4.13	13.44	1.46
Astrazeneca Pharma India Ltd ₹5,424.45(+90.60/1.70%)	5,424.45	+90.60	13,561.13	67.79	85.02	20.71
Bliss GVS Pharma Ltd ₹119.10(-10.10/-7.82%)	119.10	-10.10	1,246.87	67.42	18.27	1.28
Cipla Ltd ₹1,424.75(+5.20/0.37%)	1,424.75	+5.20	115,033.60	54.95	34.98	4.44
Amrutanjan Health Care Ltd ₹775.50(-11.10/-1.41%)	775.50	-11.10	2,242.02	29.81	50.95	8.56
Abbott India Ltd ₹26,144.45(-459.90/-1.73%)	26,144.45	-459.90	55,556.96	18.89	48.50	17.87

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	520.39	545.30	563.18	587.21	523.48	541.41
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	520.39	545.30	563.18	587.21	523.48	541.41
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	8.38	7.11	7.06	8.72	6.64	5.06
Total Income	528.77	552.41	570.24	595.93	530.12	546.47
Total Expenditure	475.91	481.20	490.32	491.42	480.44	509.74
PBIDT	52.86	71.21	79.92	104.51	49.68	36.73
Interest	4.30	4.44	3.95	4.88	4.70	3.51
PBDT	48.56	66.77	75.97	99.63	44.98	33.22
Depreciation	16.32	15.67	14.44	12.10	11.73	11.32
Tax	6.28	11.11	14.60	18.58	9.83	5.69
Deferred Tax	2.73	2.20	0.72	3.68	-0.73	0.54
Reported Profit After Tax	23.23	37.79	46.21	65.27	24.15	15.67
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	23.23	37.79	46.21	65.27	24.15	15.67

EPS (Unit Curr.)	3.96	6.44	7.87	11.11	4.12	2.67
EPS (Adj) (Unit Curr.)	3.96	6.44	7.87	11.11	4.12	2.67
Calculated EPS (Unit Curr.)	3.96	6.44	7.87	11.12	4.11	2.67
Calculated EPS (Adj) (Unit Curr.)	3.96	6.44	7.87	11.12	4.11	2.67
Calculated EPS (Ann.) (Unit Curr.)	15.83	25.75	31.48	44.47	16.45	10.68
Calculated EPS (Adj) (Ann.) (Unit Curr.)	15.83	25.75	31.48	44.47	16.45	10.68
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	50.00	0.00	0.00	0.00	40.00	0.00
Equity	58.71	58.71	58.71	58.71	58.71	58.71
Reserve & Surplus	1553.47	1530.13	1492.82	1447.84	1405.28	1381.33
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	10.16	13.06	14.19	17.80	9.49	6.78
PBDTM(%)	9.33	12.24	13.49	16.97	8.59	6.14
PATM(%)	4.46	6.93	8.21	11.12	4.61	2.89

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	520.39	545.30	563.18	587.21	523.48	541.41
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	520.39	545.30	563.18	587.21	523.48	541.41
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	8.38	7.11	7.06	8.73	6.65	5.07
Total Income	528.77	552.41	570.24	595.94	530.13	546.48
Total Expenditure	476.04	481.10	490.66	491.91	480.80	509.51
PBIDT	52.73	71.31	79.58	104.03	49.33	36.97
Interest	4.30	4.44	3.95	4.88	4.70	3.51
PBDT	48.43	66.87	75.63	99.15	44.63	33.46
Depreciation	16.34	15.69	14.45	12.11	11.75	11.32
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	6.28	11.11	14.60	18.58	9.83	5.69
Deferred Tax	2.73	2.20	0.72	3.68	-0.73	0.54
Reported Profit After Tax	23.08	37.87	45.86	64.78	23.78	15.91
Minority Interest After NP	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit after Minority Interest	23.08	37.87	45.86	64.78	23.78	15.91

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	23.08	37.87	45.86	64.78	23.78	15.91

EPS (Unit Curr.)	3.93	6.45	7.81	11.03	4.05	2.71
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	50.00	0.00	0.00	0.00	40.00	0.00
Equity	58.71	58.71	58.71	58.71	58.71	58.71

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	10.13	13.08	14.13	17.72	9.42	6.83
PBDTM(%)	9.31	12.26	13.43	16.88	8.53	6.18
PATM(%)	4.44	6.94	8.14	11.03	4.54	2.94

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	58.71	58.71	58.71	56.89	56.89	56.21
Reserves Total	1447.84	1331.56	1201.72	747.33	408.13	159.53
Equity Share Warrants	0.00	0.00	0.00	9.32	9.32	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	1506.55	1390.27	1260.43	813.54	474.34	215.74
Secured Loans	79.63	42.75	0.00	55.99	284.00	415.58
Unsecured Loans	0.18	1.20	2.73	3.50	0.00	6.30
Total Debt	79.81	43.95	2.73	59.49	284.00	421.88
Total Liabilities	1586.36	1434.22	1263.16	873.03	758.34	637.62
APPLICATION OF FUNDS :
Gross Block	993.88	761.99	676.81	596.66	503.91	465.53
Less : Accumulated Depreciation	242.57	201.35	164.45	127.62	92.19	59.89
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	751.31	560.64	512.36	469.04	411.72	405.64
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	89.64	105.20	48.27	19.19	27.02	6.95
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	20.27	2.47	1.22	0.05	0.06	0.06
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	325.52	409.89	295.15	187.52	188.86	207.45
Sundry Debtors	505.28	469.80	300.31	272.42	199.16	146.14
Cash and Bank	20.90	137.88	364.74	154.65	29.60	17.32
Loans and Advances	64.81	58.77	48.48	56.16	66.60	53.70
Total Current Assets	916.51	1076.34	1008.68	670.75	484.22	424.61
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	367.97	462.29	278.93	214.00	157.75	180.09
Provisions	8.13	7.34	10.72	5.76	5.02	0.81
Total Current Liabilities	376.10	469.63	289.65	219.76	162.77	180.90
Net Current Assets	540.41	606.71	719.03	450.99	321.45	243.71
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	3.97	2.91	2.54	4.84	3.01	84.33
Deferred Tax Liability	60.33	56.09	55.76	77.48	18.54	72.91
Net Deferred Tax	-56.36	-53.18	-53.22	-72.64	-15.53	11.42
Total Assets	1345.27	1221.84	1227.66	866.63	744.72	667.78
Contingent Liabilities	5.35	0.18	0.52	0.52	0.74	0.21

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	1.12	32.34	28.09	13.41	0.74
Net Cash from Operating Activities	123.14	91.04	379.78	470.80	273.17
Net Cash Used In Investing Activities	-119.19	-120.62	-317.25	-184.23	-63.04
Net Cash Used In Financing Activities	-4.11	-1.64	-58.28	-271.89	-197.46
Net Inc./Dec In Cash And Cash Equivalents	-0.16	-31.22	4.25	14.68	12.67
Cash And Cash Equivalents At End Of The Year	0.96	1.12	32.34	28.09	13.41

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

48.19%

FII Shareholding

1.41%

DII Shareholding

0.30%

Public Shareholding

50.10%

**Promoter pledged shareholding 48.19%

About IOL Chemicals & Pharmaceuticals Ltd

IOL Chemicals & Pharmaceuticals Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 2318.28 crores. It has reported a sales of Rs. 520.39 crores and a net profit of Rs. 23.23 crores for the quarter ended December 2018. The company management includes Rajender Mohan Malla, Varinder Gupta,Sandhya Mehta,Vikas Gupta,Rajender Mohan Malla,Harpal Singh,Abhay Raj Singh,Kushal Kumar Rana,SHARAD TYAGI,Abhiraj Gupta (IOL Chemicals & Pharmaceuticals Ltd) among others.

Chairman

Rajender Mohan Malla

Registered office

Trident Complex,Raikot Road Barnala,Sangrur,Punjab,148101

FAX :91-01679-244708

Background

Incorporation Year1986

Face Value₹10

Market Lot1

How to buy IOL Chemicals shares on nse?

To buy IOL Chemicals shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the IOL Chemicals share price today?

The IOL Chemicals shares price on nse is Rs.394.9 today.

What is the market cap of IOL Chemicals shares on BSE ?

The company has a market capitalization of Rs.2318.28Cr

What is the PE & PB ratio of IOL Chemicals shares ?

PE is 13.44 and PB is 1.46

What is the 52 Week High and Low of IOL Chemicals shares?

IOL Chemicals stock price high: Rs.535.6 IOL Chemicals stock price low: Rs.350.3